Lorna Staines discusses a recent Swedish cross-sectional study of 16,255 adolescent twins, which looks at the mental health risks of using psychedelics in the real world.
[read the full story...]Alternatives to medication for ‘treatment-resistant schizophrenia’
Kalya Win Aung, Angela Kibia and Dorothy Williams consider a systematic review and network meta-analysis published by the Lancet Psychiatry on psychological and psychosocial interventions for treatment-resistant schizophrenia.
[read the full story...]HRT associated with reduced risk of psychosis relapse in middle-age women
Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.
[read the full story...]Omega-3 supplements for the prevention of psychosis: another trial shows no benefit, so is it time to move on?
David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]The role of the gut microbiome in treatment-resistant schizophrenia
Nuala Murray explores a recent Australian case-control study that looks at the associations between changes in gut microbiota and schizophrenia diagnosis, treatment resistance, and clozapine response.
[read the full story...]The many faces of mental disorders
Yuri Milaneschi discusses new research on the structure and presentation of mental health disorders, which suggests that although there are many different faces of major mental disorders, some of these faces are far more common than others.
[read the full story...]Childhood neglect: the neglected trauma?
Dhea Bengardi summarises a systematic review exploring the prevalence of different types of neglect across a wide variety of mental health conditions.
[read the full story...]KarXT: an innovative and promising treatment for schizophrenia
Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.
[read the full story...]The influence of the menopause in first onset of mental illness
Katie Marwick on a new UK Biobank study which suggests that the two years either side of the final menstrual period represent a time of small increased risk for new onset bipolar and major depressive disorder.
[read the full story...]Mental illness is linked to being a victim and/or perpetrator of violence: time to face up to some inconvenient truths?
Anabelle Paulino and Maya Ogonah summarise a recent Danish longitudinal study on the risk of violent victimisation and perpetration following the onset of mental illness.
[read the full story...]